‘The label should be changed’: HHS Sec Kennedy pledges to review FDA approval of abortion drug
“We respectfully ask that you take swift action to protect the rights of states to defend unborn children, in keeping with your campaign pledge to return the issue of abortion to the states”
Health and Human Services Secretary Robert F. Kennedy, Jr. said Wednesday that he has ordered a top-down review of the abortion drug mifepristone in light of “alarming” research showing the Food and Drug Administration (FDA)-approved pill does far more harm to women than previously reported.
The
latest research is “alarming,” Kennedy said during a hearing before the
Senate Health, Education, Labor and Pensions Committee. “And clearly it
indicates at the very least the [FDA] label should be changed.” ---More...
A new study on the chemical abortion drug shows 11% of women experience adverse effects serious enough to send them to the ER@SecKennedy just pledged to conduct a top-to-bottom review of the drug - and said the FDA label needs to change
— Josh Hawley (@HawleyMO)May 14, 2025
That's a win for life pic.twitter.com/gy65iCZjI5
Read next: EPA to screen America’s drinking water for abortion drugs, other potential pollutants